Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1956 2
1957 1
1958 1
1967 1
1969 1
1982 1
1992 1
1997 1
2000 1
2001 1
2002 2
2003 2
2004 2
2005 1
2006 1
2007 6
2008 7
2009 4
2010 6
2011 9
2012 6
2013 8
2014 7
2015 9
2016 10
2017 8
2018 7
2019 8
2020 10
2021 18
2022 30
2023 51
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions.
Damelin M, Bankovich A, Bernstein J, Lucas J, Chen L, Williams S, Park A, Aguilar J, Ernstoff E, Charati M, Dushin R, Aujay M, Lee C, Ramoth H, Milton M, Hampl J, Lazetic S, Pulito V, Rosfjord E, Sun Y, King L, Barletta F, Betts A, Guffroy M, Falahatpisheh H, O'Donnell CJ, Stull R, Pysz M, Escarpe P, Liu D, Foord O, Gerber HP, Sapra P, Dylla SJ. Damelin M, et al. Among authors: barletta f. Sci Transl Med. 2017 Jan 11;9(372):eaag2611. doi: 10.1126/scitranslmed.aag2611. Sci Transl Med. 2017. PMID: 28077676
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
Gandaglia G, Barletta F, Robesti D, Scuderi S, Rajwa P, Gomez Rivas J, Ibanez L, Soeterik TFW, Bianchi L, Afferi L, Kesch C, Darr C, Guo H, Zhuang J, Zattoni F, Fendler W, Marra G, Stabile A, Amparore D, Huebner NA, Giesen A, Joniau S, Schiavina R, Brunocilla E, Mattei A, Dal Moro F, Sierra JM, Porpiglia F, Picchio M, van den Bergh R, Shariat SF, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: barletta f. Eur Urol Oncol. 2023 Dec;6(6):543-552. doi: 10.1016/j.euo.2023.05.003. Epub 2023 Jun 1. Eur Urol Oncol. 2023. PMID: 37270378
Characteristics of incidental prostate cancer in the United States.
Scheipner L, Incesu RB, Morra S, Baudo A, Assad A, Jannello LMI, Siech C, de Angelis M, Barletta F, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Tilki D, Longo N, Carmignani L, De Cobelli O, Ahyai S, Karakiewicz PI. Scheipner L, et al. Among authors: barletta f. Prostate Cancer Prostatic Dis. 2023 Oct 23. doi: 10.1038/s41391-023-00742-7. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37872250
Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS.
Aly A, Laszlo ZI, Rajkumar S, Demir T, Hindley N, Lamont DJ, Lehmann J, Seidel M, Sommer D, Franz-Wachtel M, Barletta F, Heumos S, Czemmel S, Kabashi E, Ludolph A, Boeckers TM, Henstridge CM, Catanese A. Aly A, et al. Among authors: barletta f. Acta Neuropathol. 2023 Sep;146(3):451-475. doi: 10.1007/s00401-023-02611-y. Epub 2023 Jul 24. Acta Neuropathol. 2023. PMID: 37488208 Free PMC article.
Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era.
Scheipner L, Barletta F, Cano Garcia C, Incesu RB, Morra S, Baudo A, Assad A, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Tilki D, Longo N, Carmignani L, Pichler M, Ahyai S, Karakiewicz PI. Scheipner L, et al. Among authors: barletta f. Ann Surg Oncol. 2023 Dec;30(13):8780-8785. doi: 10.1245/s10434-023-14367-6. Epub 2023 Oct 10. Ann Surg Oncol. 2023. PMID: 37815682 Free PMC article.
Is Active Surveillance an Option for the Management of Men with Low-grade Prostate Cancer and a Positive Family History? Results from a Large, Single-institution Series.
Leni R, Gandaglia G, Stabile A, Mazzone E, Pellegrino F, Scuderi S, Robesti D, Barletta F, Cirulli GO, Cucchiara V, Zaffuto E, Dehò F, Montorsi F, Briganti A. Leni R, et al. Among authors: barletta f. Eur Urol Oncol. 2023 Oct;6(5):493-500. doi: 10.1016/j.euo.2023.02.014. Epub 2023 Mar 31. Eur Urol Oncol. 2023. PMID: 37005213
Oncological and perioperative outcomes of surgery with or without metastasis-directed therapy as part of a multimodal treatment in men with de-novo oligometastatic prostate cancer.
Pellegrino A, Gandaglia G, de Angelis M, Fallara G, Mazzone E, Stabile A, Pellegrino F, Robesti D, Leni R, Scuderi S, Cucchiara V, Cirulli GO, Barletta F, Montorsi F, Briganti A. Pellegrino A, et al. Among authors: barletta f. World J Urol. 2023 Aug;41(8):2069-2076. doi: 10.1007/s00345-023-04460-6. Epub 2023 Jun 16. World J Urol. 2023. PMID: 37326656
207 results